Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Environmental Radioactivity|January 29, 2023
Identification and quantification of anomalies in environmental gamma dose rate time series using artificial intelligenceHarald Breitkreutz, Josef Mayr, Martin Bleher, et al.
Plants (Basel, Switzerland)|November 9, 2024
Trees Are a Major Foraging Resource for Honeybees in the CityKaren Koelzer, Alexandra Ribarits, Karin Weyermair, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 2, 2020
Improving the Stability of Maleimide-Thiol Conjugation for Drug TargetingMarianne Lahnsteiner, Alexander Kastner, Josef Mayr, et al.
Gels (Basel, Switzerland)|July 25, 2025
A Scientific Framework for Comparing Hyaluronic Acid Filler Crosslinking TechnologiesAnto Puljic, Konstantin Frank, Joel Cohen, et al.
Angewandte Chemie (International Ed. in English)|March 15, 2019
A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt<sup>IV</sup> Complexes under Physiological ConditionsAlexander Kastner, Isabella Poetsch, Josef Mayr, et al.
Bioconjugate Chemistry|August 11, 2017
Multifunctional α<sub>v</sub>β<sub>6</sub> Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell TargetingAnne C Conibear, Sonja Hager, Josef Mayr, et al.
Chemical Science|May 17, 2017
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity <i>in vivo</i>Josef Mayr, Petra Heffeter, Diana Groza, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 14, 2017
EGFR-targeting peptide-coupled platinum(IV) complexesJosef Mayr, Sonja Hager, Bettina Koblmüller, et al.
Chemical Communications (Cambridge, England)|February 12, 2013
Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug deliveryVerena Pichler, Josef Mayr, Petra Heffeter, et al.
Chemical Science|October 27, 2021
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake <i>in vivo</i>Hemma Schueffl, Sarah Theiner, Gerrit Hermann, et al.
Pageof 2